{"id":6125,"date":"2023-11-16T10:00:00","date_gmt":"2023-11-16T08:00:00","guid":{"rendered":"https:\/\/eu.bd.com\/iv-news\/?p=1088"},"modified":"2025-06-04T15:07:30","modified_gmt":"2025-06-04T13:07:30","slug":"picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2","status":"publish","type":"post","link":"https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/","title":{"rendered":"PICC o port: quale utilizzare nei pazienti oncologici?"},"content":{"rendered":"<p><span data-contrast=\"none\">Pu\u00f2 essere difficile sapere quando inserire un catetere centrale ad inserimento periferico (PICC) o un port nei pazienti oncologici.\u00a0<\/span><span data-contrast=\"none\">La scelta del catetere venoso centrale (CVC) \u00e8 fondamentale in oncologia.\u00a0<\/span><span data-contrast=\"none\">Come professionista oncologico, \u00e8 necessario considerare molteplici fattori. <\/span><span data-contrast=\"none\">Diverse opzioni comportano diversi vantaggi e potenziali complicanze.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<h2>Quali sono i vantaggi dei PICC?<\/h2>\n<p><span data-contrast=\"auto\">Dopo la fine della Seconda Guerra Mondiale, furono sviluppate le mostarde azotate come primi farmaci chemioterapici<\/span><sup><span data-contrast=\"auto\">1<\/span><\/sup><span data-contrast=\"auto\">.\u00a0<\/span><span data-contrast=\"auto\">Il port totalmente impiantabile \u00e8 stato introdotto da Niederhuber nel 1982<\/span><sup><span data-contrast=\"auto\">2<\/span><\/sup><span data-contrast=\"auto\">. <\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<h3><span data-contrast=\"auto\">I PICC<\/span><span data-contrast=\"none\"> sono disponibili dagli anni &#8217;70, ma il loro utilizzo \u00e8 aumentato in modo significativo dal 2000 per diversi motivi<\/span><sup><span data-contrast=\"none\">3<\/span><\/sup><span data-contrast=\"auto\">:<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/h3>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"21\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;multilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"none\">Facilit\u00e0 di posizionamento<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"21\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;multilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"none\">Guida ecografica che garantisce un posizionamento corretto<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"21\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;multilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"none\">Costo di inserimento inferiore rispetto ad altri CVC<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"21\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;multilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\"><span data-contrast=\"none\">Minor rischio di sanguinamento<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"21\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;multilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\"><span data-contrast=\"none\">Facilit\u00e0 di rimozione<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<h2>Quali sono i rischi potenziali associati ai CVC?<\/h2>\n<h3>1. Qual \u00e8 il rischio di infezioni del sangue (BSI) tra diversi CVC?<\/h3>\n<p><span data-contrast=\"none\">In uno studio retrospettivo di Mielke et al., \u00e8 emerso che i port hanno tassi di incidenza pi\u00f9 bassi di BSI (0,1\u20130,2 per 1.000 giorni catetere)<\/span><span data-contrast=\"none\">4<\/span><span data-contrast=\"none\">; i CVC non tunnellizzati hanno i tassi pi\u00f9 elevati (2,3\u20132,7 per 1.000 giorni-catetere)<\/span><span data-contrast=\"none\">4<\/span><span data-contrast=\"none\">; i PICC hanno livelli di incidenza medi (0,4\u20132,1 per 1.000 giorni-catetere)<\/span><sup><span data-contrast=\"none\">4<\/span><\/sup><span data-contrast=\"none\">.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559685&quot;:1440,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<h3>2. Qual \u00e8 il rischio di trombosi tra port e PICC?<\/h3>\n<p><span data-contrast=\"none\">La trombosi \u00e8 pi\u00f9 comune nei pazienti oncologici rispetto a quelli non oncologici<\/span><sup><span data-contrast=\"none\">5<\/span><\/sup><span data-contrast=\"none\">.\u00a0<\/span><span data-contrast=\"none\">Nelle revisioni sistematiche condotte da Sabre et al. e Yeow et al., \u00e8 stato riscontrato che i tassi di trombosi erano pi\u00f9 elevati nei pazienti con PICC rispetto a quelli con port<\/span><sup><span data-contrast=\"none\">6,7<\/span><\/sup><span data-contrast=\"none\">.\u00a0<\/span><span data-contrast=\"none\">Tuttavia, Chopra et al. ha indicato che i tassi di trombosi per i PICC possono variare in base alle tecniche utilizzate per posizionarli<sup>5<\/sup>.\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:false,&quot;201341983&quot;:0,&quot;335559685&quot;:1440,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/eu.bd.com\/iv-news\/news-innovation\/effect-of-technology-changes-%E2%80%A8insertion-of-picc-line-using-ultrasound-navigation-equipment-in-an-oncology-department\/\"><span data-contrast=\"none\">Gli strumenti per la navigazione ecografica <\/span><\/a><span data-contrast=\"none\">possono essere utilizzati per garantire il posizionamento nel vaso appropriato<\/span><sup><span data-contrast=\"none\">3<\/span><\/sup><span data-contrast=\"none\">.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559685&quot;:1440,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<h3>3. Quali sono i tassi di complicanze correlate al catetere EV per i PICC?<\/h3>\n<p><span data-contrast=\"none\">Il Prof. Baudolino Mussa dell&#8217;Universit\u00e0 di Torino e colleghi hanno effettuato uno studio prospettico sui PICC in pazienti ambulatoriali oncologici<\/span><sup><span data-contrast=\"none\">3<\/span><\/sup><span data-contrast=\"none\">.\u00a0<\/span><span data-contrast=\"none\">Hanno scoperto che i tassi di complicanze correlate al catetere EV (CRBSI, trombosi e complicanze meccaniche) erano bassi con i PICC<\/span><sup><span data-contrast=\"none\">3<\/span><\/sup><span data-contrast=\"none\">.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559685&quot;:1440,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Principalmente, Mussa et al. hanno riscontrato che, quando i PICC vengono gestiti correttamente utilizzando <\/span><a href=\"https:\/\/eu.bd.com\/iv-news\/news-innovation\/assessment-of-the-michigan-appropriateness-guide-for-intravenous-catheters-magic-2015-recommendations-in-the-context-of-evolving-evidence-based-on-the-use-of-peripherally-inserted-central-catheters-pi\/\"><span data-contrast=\"none\">protocolli basati sull&#8217;evidenza<\/span><\/a><span data-contrast=\"none\">, hanno tassi di complicanze relativamente bassi, hanno meno probabilit\u00e0 di essere rimossi a causa di complicanze e consentono di usare il catetere a lungo<\/span><sup><span data-contrast=\"none\">3<\/span><\/sup><span data-contrast=\"none\">.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559685&quot;:1440,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n\t\t\t\t\t<div class=\"gated_content\" id=\"gated_content-66fd11b23cfc6\">\n\t\t\t\t\t\t<div class=\"labelform notice-box margin-full\">\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<i class=\"fa fa-exclamation-triangle\" aria-hidden=\"true\"><\/i>\n\t\t\t\t\t\t\t\tDiventa un VAMbassador per accedere all'articolo completo\t\t\t\t\t\t\t<\/p>\n\n\t\t\t\t\t\t\t<div class=\"loginwrapper\">\n\t\t\t\t\t\t\t\t<form name=\"loginform\" id=\"loginform\" method=\"post\">\n\n\t\t\t\t\t\t\t\t\t<p class=\"login-username\">\n\t\t\t\t\t\t\t\t\t\t<label for=\"user_login\"><\/label>\n\t\t\t\t\t\t\t\t\t\t<input required type=\"email\" name=\"log\" placeholder=\"Email address\" id=\"user_login\" class=\"input\" size=\"20\">\n\t\t\t\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t\t\t\t<p class=\"login-password\">\n\t\t\t\t\t\t\t\t\t\t<label for=\"user_pass\"><\/label>\n\t\t\t\t\t\t\t\t\t\t<input required type=\"password\" name=\"pwd\" placeholder=\"Password\" id=\"user_pass\" class=\"input\" size=\"20\">\n\t\t\t\t\t\t\t\t\t\t<i class='fa fa-eye showpwd'><\/i>\n\t\t\t\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t\t\t\t<p class=\"login-submit\">\n\t\t\t\t\t\t\t\t\t\t<input type=\"submit\" name=\"wp-submit\" id=\"wp-submit\" class=\"button button-primary\" value=\"Login\">\n\t\t\t\t\t\t\t\t\t\t<input type=\"hidden\" name=\"redirect_to\" value=\"https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/#gated_content-66fd11b23cfc6\">\n\t\t\t\t\t\t\t\t\t<\/p>\n\n\t\t\t\t\t\t\t\t\t<div class=\"aa_error hide\">\n\t\t\t\t\t\t\t\t\t\t<p><\/p>\n\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t\t\t<\/form>\n\n\t\t\t\t\t\t\t\t<div class='extralink'>\n\t\t\t\t\t\t\t\t\t<a class=\"forgot\" href=\"https:\/\/eu.bd.com\/iv-news\/it\/password-persa\/\">\n\t\t\t\t\t\t\t\t\t\tForgot your password?\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t<br \/>\n\t\t\t\t\t\t\t\t\t<a class=\"register\" href=\"https:\/\/eu.bd.com\/iv-news\/fr\/inscription\/\">\n\t\t\t\t\t\t\t\t\t\tNot registered yet? <strong> Sign up <\/strong>\n\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<div class=\"content\" style=\"display:none;\">\n\t\t\t\t\t\t\t<h3>4. I PICC possono essere un metodo sicuro per la somministrazione della chemioterapia?<\/h3>\n<p><span data-contrast=\"none\">In uno studio di sette anni condotto su 2.477 pazienti, Campagna et al hanno scoperto che i PICC possono essere sicuri per la somministrazione di farmaci oncologici a medio-lungo termine con bassi tassi di infezione e trombosi<\/span><sup><span data-contrast=\"none\">8<\/span><\/sup><span data-contrast=\"none\">.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559685&quot;:1440,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<h2>Scegliere un CVC adatto alle esigenze specifiche dei tuoi pazienti<\/h2>\n<h3>Quando possono essere utilizzati i port?<\/h3>\n<p><span data-contrast=\"auto\">Mielke et al. sconsigliano l&#8217;uso dei port per meno di 30 giorni<\/span><span data-contrast=\"auto\">4<\/span><span data-contrast=\"auto\">. Non devono essere utilizzati per protocolli di radiazione standard (meno di 60 giorni)<\/span><sup><span data-contrast=\"auto\">4<\/span><\/sup><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559685&quot;:1440,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<h3>Quando possono essere utilizzati i PICC?<\/h3>\n<p><span data-contrast=\"none\">Secondo Mussa et al., i PICC possono essere utilizzati in modo sicuro nei pazienti oncologici se inseriti e gestiti correttamente<\/span><sup><span data-contrast=\"none\">3<\/span><\/sup><span data-contrast=\"none\">.\u00a0<\/span><span data-contrast=\"none\">La loro durata pu\u00f2 essere estesa da poche settimane fino a 6 mesi<\/span><sup><span data-contrast=\"none\">4<\/span><\/sup><span data-contrast=\"none\">.\u00a0<\/span><span data-contrast=\"none\">A differenza dei port che richiedono un intervento chirurgico minore per il posizionamento, i PICC offrono il vantaggio di un minor rischio di traumi correlati alla procedura<\/span><sup><span data-contrast=\"auto\">4<\/span><\/sup><span data-contrast=\"none\">.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559685&quot;:1440,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<h2>In conclusione: non esiste un CVC che va bene per tutti<\/h2>\n<p><span data-contrast=\"none\">Non \u00e8 possibile utilizzare lo stesso CVC in tutti i pazienti. \u00c8 importante scegliere il CVC appropriato in base alle esigenze del paziente<\/span><sup><span data-contrast=\"none\">9<\/span><\/sup><span data-contrast=\"none\">.\u00a0<\/span><span data-contrast=\"none\">Il Prof. Mussa ritiene che questa strategia possa essere in grado di ridurre i costi, diminuire il dolore nei pazienti e migliorare la qualit\u00e0 del trattamento.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559685&quot;:1440,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Per ulteriori informazioni, guarda la sua <a href=\"https:\/\/lp.bd.com\/202004-MDS20-EU_EN-MACOVA-post_com-speakers_presentation-LP_LP-EN-01-MainLP.html\">presentazione<\/a> su questo argomento.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559685&quot;:1440,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\n","protected":false},"excerpt":{"rendered":"<p>Pu\u00f2 essere difficile sapere quando inserire un catetere centrale ad inserimento periferico (PICC) o un port nei pazienti oncologici.\u00a0La scelta&#8230;<\/p>\n","protected":false},"author":2,"featured_media":6771,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5629,753],"tags":[],"class_list":["post-6125","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gated-content","category-novita-e-innovazione"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PICC o port: quale utilizzare nei pazienti oncologici? - BD IV News<\/title>\n<meta name=\"description\" content=\"PICC o port? L&#039;accesso venoso centrale \u00e8 fondamentale in oncologia. Diverse opzioni comportano diversi vantaggi e potenziali complicanze.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PICC o port: quale utilizzare nei pazienti oncologici? - BD IV News\" \/>\n<meta property=\"og:description\" content=\"PICC o port? L&#039;accesso venoso centrale \u00e8 fondamentale in oncologia. Diverse opzioni comportano diversi vantaggi e potenziali complicanze.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/\" \/>\n<meta property=\"og:site_name\" content=\"BD IV News\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-16T08:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-04T13:07:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2023\/11\/Oncology_port_picc-1-2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1222\" \/>\n\t<meta property=\"og:image:height\" content=\"520\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Nina\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nina\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/it\\\/novita-e-innovazione\\\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/it\\\/novita-e-innovazione\\\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\\\/\"},\"author\":{\"name\":\"Nina\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/person\\\/59d9241f163013af9a439ffa23a0d44a\"},\"headline\":\"PICC o port: quale utilizzare nei pazienti oncologici?\",\"datePublished\":\"2023-11-16T08:00:00+00:00\",\"dateModified\":\"2025-06-04T13:07:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/it\\\/novita-e-innovazione\\\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\\\/\"},\"wordCount\":382,\"publisher\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/it\\\/novita-e-innovazione\\\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/Oncology_port_picc-1-2.webp\",\"articleSection\":[\"Gated Content\",\"Novit\u00e0 e innovazione\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/it\\\/novita-e-innovazione\\\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\\\/\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/it\\\/novita-e-innovazione\\\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\\\/\",\"name\":\"PICC o port: quale utilizzare nei pazienti oncologici? - BD IV News\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/it\\\/novita-e-innovazione\\\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/it\\\/novita-e-innovazione\\\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/Oncology_port_picc-1-2.webp\",\"datePublished\":\"2023-11-16T08:00:00+00:00\",\"dateModified\":\"2025-06-04T13:07:30+00:00\",\"description\":\"PICC o port? L'accesso venoso centrale \u00e8 fondamentale in oncologia. Diverse opzioni comportano diversi vantaggi e potenziali complicanze.\",\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/it\\\/novita-e-innovazione\\\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/it\\\/novita-e-innovazione\\\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/Oncology_port_picc-1-2.webp\",\"contentUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/Oncology_port_picc-1-2.webp\",\"width\":1222,\"height\":520},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#website\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/\",\"name\":\"BD IV News\",\"description\":\"Your source of information on intravenous therapy, medication delivery and vascular access management.\",\"publisher\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#organization\",\"name\":\"BD IV News\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/BD-Master-Logo-on-Warm-White-512X512px.png\",\"contentUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/BD-Master-Logo-on-Warm-White-512X512px.png\",\"width\":512,\"height\":512,\"caption\":\"BD IV News\"},\"image\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/person\\\/59d9241f163013af9a439ffa23a0d44a\",\"name\":\"Nina\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7aa0c783d41a4a6797b60cd4ad873f4f56f4d1d7d5c4a7795789a531f0ca6e1f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7aa0c783d41a4a6797b60cd4ad873f4f56f4d1d7d5c4a7795789a531f0ca6e1f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7aa0c783d41a4a6797b60cd4ad873f4f56f4d1d7d5c4a7795789a531f0ca6e1f?s=96&d=mm&r=g\",\"caption\":\"Nina\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PICC o port: quale utilizzare nei pazienti oncologici? - BD IV News","description":"PICC o port? L'accesso venoso centrale \u00e8 fondamentale in oncologia. Diverse opzioni comportano diversi vantaggi e potenziali complicanze.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/","og_locale":"en_GB","og_type":"article","og_title":"PICC o port: quale utilizzare nei pazienti oncologici? - BD IV News","og_description":"PICC o port? L'accesso venoso centrale \u00e8 fondamentale in oncologia. Diverse opzioni comportano diversi vantaggi e potenziali complicanze.","og_url":"https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/","og_site_name":"BD IV News","article_published_time":"2023-11-16T08:00:00+00:00","article_modified_time":"2025-06-04T13:07:30+00:00","og_image":[{"width":1222,"height":520,"url":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2023\/11\/Oncology_port_picc-1-2.webp","type":"image\/webp"}],"author":"Nina","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nina","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/#article","isPartOf":{"@id":"https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/"},"author":{"name":"Nina","@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/person\/59d9241f163013af9a439ffa23a0d44a"},"headline":"PICC o port: quale utilizzare nei pazienti oncologici?","datePublished":"2023-11-16T08:00:00+00:00","dateModified":"2025-06-04T13:07:30+00:00","mainEntityOfPage":{"@id":"https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/"},"wordCount":382,"publisher":{"@id":"https:\/\/eu.bd.com\/iv-news\/#organization"},"image":{"@id":"https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/#primaryimage"},"thumbnailUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2023\/11\/Oncology_port_picc-1-2.webp","articleSection":["Gated Content","Novit\u00e0 e innovazione"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/","url":"https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/","name":"PICC o port: quale utilizzare nei pazienti oncologici? - BD IV News","isPartOf":{"@id":"https:\/\/eu.bd.com\/iv-news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/#primaryimage"},"image":{"@id":"https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/#primaryimage"},"thumbnailUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2023\/11\/Oncology_port_picc-1-2.webp","datePublished":"2023-11-16T08:00:00+00:00","dateModified":"2025-06-04T13:07:30+00:00","description":"PICC o port? L'accesso venoso centrale \u00e8 fondamentale in oncologia. Diverse opzioni comportano diversi vantaggi e potenziali complicanze.","inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/eu.bd.com\/iv-news\/it\/novita-e-innovazione\/picc-o-port-qual-e-il-dispositivo-migliore-per-i-pazienti-con-cancro-2\/#primaryimage","url":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2023\/11\/Oncology_port_picc-1-2.webp","contentUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2023\/11\/Oncology_port_picc-1-2.webp","width":1222,"height":520},{"@type":"WebSite","@id":"https:\/\/eu.bd.com\/iv-news\/#website","url":"https:\/\/eu.bd.com\/iv-news\/","name":"BD IV News","description":"Your source of information on intravenous therapy, medication delivery and vascular access management.","publisher":{"@id":"https:\/\/eu.bd.com\/iv-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eu.bd.com\/iv-news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/eu.bd.com\/iv-news\/#organization","name":"BD IV News","url":"https:\/\/eu.bd.com\/iv-news\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/logo\/image\/","url":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2024\/04\/BD-Master-Logo-on-Warm-White-512X512px.png","contentUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2024\/04\/BD-Master-Logo-on-Warm-White-512X512px.png","width":512,"height":512,"caption":"BD IV News"},"image":{"@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/person\/59d9241f163013af9a439ffa23a0d44a","name":"Nina","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/7aa0c783d41a4a6797b60cd4ad873f4f56f4d1d7d5c4a7795789a531f0ca6e1f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7aa0c783d41a4a6797b60cd4ad873f4f56f4d1d7d5c4a7795789a531f0ca6e1f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7aa0c783d41a4a6797b60cd4ad873f4f56f4d1d7d5c4a7795789a531f0ca6e1f?s=96&d=mm&r=g","caption":"Nina"}}]}},"lang":"it","translations":{"it":6125,"en":387,"de":6123,"es":823,"fr":6124},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts\/6125","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/comments?post=6125"}],"version-history":[{"count":3,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts\/6125\/revisions"}],"predecessor-version":[{"id":8932,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts\/6125\/revisions\/8932"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/media\/6771"}],"wp:attachment":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/media?parent=6125"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/categories?post=6125"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/tags?post=6125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}